L Biganzoli Selected Research

L Biganzoli Research Topics

Disease

31	Breast Neoplasms (Breast Cancer) 01/2018 - 02/2000
9	Neoplasms (Cancer) 11/2015 - 02/2000
5	Disease Progression 01/2018 - 02/2000
4	Febrile Neutropenia 12/2017 - 11/2001
3	Neoplasm Metastasis (Metastasis) 02/2016 - 06/2003
3	Neutropenia 11/2003 - 11/2001
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 12/2019 - 04/2019
2	Cardiotoxicity 01/2017 - 10/2010
2	Cardiovascular Diseases (Cardiovascular Disease) 02/2016 - 06/2002
2	Hypertension (High Blood Pressure) 01/2012 - 03/2011
2	Infections 02/2005 - 11/2003
2	Inflammatory Breast Neoplasms 06/2003 - 11/2001
1	Rare Diseases (Rare Disease) 04/2019
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2015
1	Lung Neoplasms (Lung Cancer) 11/2015
1	Colorectal Neoplasms (Colorectal Cancer) 11/2015
1	Brain Neoplasms (Brain Tumor) 07/2015
1	Infertility (Sterility) 09/2013
1	Long Term Adverse Effects 09/2013
1	Primary Ovarian Insufficiency 09/2013
1	Venous Thromboembolism 03/2011
1	Proteinuria 03/2011
1	Hemorrhage 03/2011
1	Coronary Artery Disease (Coronary Atherosclerosis) 02/2004
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 11/2003
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 11/2003
1	Flushing 09/2003
1	Edema (Dropsy) 09/2003
1	Dyspnea (Shortness of Breath) 09/2003
1	Nausea 09/2003
1	Pulmonary Embolism 09/2003
1	Stomatitis 04/2002
1	Thrombosis (Thrombus) 04/2002
1	Thrombocytopenia (Thrombopenia) 11/2001
1	Alopecia (Baldness) 11/2001

Drug/Important Bio-Agent (IBA)

10	AnthracyclinesIBA 02/2016 - 04/2000
8	Cyclophosphamide (Cytoxan)FDA LinkGeneric 12/2017 - 04/2000
7	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2017 - 02/2000
6	Paclitaxel (Taxol)FDA LinkGeneric 02/2016 - 02/2000
5	Taxoids (Taxanes)IBA 02/2016 - 04/2000
4	Docetaxel (Taxotere)FDA Link 12/2017 - 03/2013
4	Trastuzumab (Herceptin)FDA Link 01/2017 - 10/2010
4	Fluorouracil (Carac)FDA LinkGeneric 11/2015 - 11/2001
3	Capecitabine (Xeloda)FDA Link 11/2015 - 06/2003
3	Epirubicin (Ellence)FDA LinkGeneric 10/2013 - 11/2001
3	Tamoxifen FDA LinkGeneric 02/2004 - 09/2000
3	exemestane (Aromasin)FDA Link 02/2004 - 09/2000
3	Hormones (Hormone)IBA 02/2004 - 09/2000
2	Carboplatin (JM8)FDA LinkGeneric 11/2015 - 11/2001
2	Cisplatin (Platino)FDA LinkGeneric 11/2015 - 11/2001
2	N,N'-bis(4-azidobenzoyl)cystineIBA 10/2014 - 10/2014
2	Bevacizumab (Avastin)FDA Link 01/2012 - 03/2011
2	taxaneIBA 03/2011 - 11/2003
2	Biological ProductsIBA 12/2007 - 02/2004
2	liposomal doxorubicin (Doxil)FDA Link 05/2006 - 06/2002
2	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2005 - 11/2003
2	thiamine triphosphorate (TTP)IBA 11/2003 - 09/2000
1	palbociclibIBA 01/2018
1	Estrogen ReceptorsIBA 01/2018
1	Anti-Bacterial Agents (Antibiotics)IBA 12/2017
1	AntigensIBA 01/2017
1	Vinorelbine (Navelbine)FDA LinkGeneric 11/2015
1	PlatinumIBA 11/2015
1	Lapatinib (GW572016)FDA Link 07/2015
1	Gonadotropin-Releasing Hormone (GnRH)FDA Link 09/2013
1	Epidermal Growth Factor (EGF)IBA 01/2012
1	human ERBB2 proteinIBA 03/2011
1	Aromatase InhibitorsIBA 02/2004
1	LipidsIBA 02/2004
1	Aromatase (CYP19)IBA 02/2004
1	E 25 (E-25)IBA 02/2004
1	CholesterolIBA 02/2004
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2003
1	Cytotoxins (Cytolysins)IBA 11/2003
1	Polyethylene Glycols (Polyethylene Glycol)FDA LinkGeneric 06/2002
1	Gemcitabine FDA Link 04/2002
1	Transaminases (Aminotransferases)IBA 04/2002
1	Platinum Compounds (Compounds, Platinum)IBA 11/2001
1	Estrogen Receptor Modulators (Antiestrogen)IBA 09/2000
1	Pharmaceutical PreparationsIBA 02/2000

Therapy/Procedure

15	Drug Therapy (Chemotherapy) 11/2015 - 02/2000
9	Therapeutics 01/2018 - 02/2000
2	Breast Implants (Breast Implant) 12/2019 - 04/2019
2	Adjuvant Chemotherapy 09/2013 - 02/2004
1	Oral Administration 11/2015
1	Radiotherapy 07/2015
1	Contraindications 11/2003